Aim for about 0.8 grams of protein per kilogram of body weight for maintenance, but if youre working on muscle gain or weight loss, your needs may rise to 1.2 to 2.0 grams per kilogram
Throw away the pen if it has been exposed for longer than 28 days
GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) are contraindicated during breastfeeding per UK Summary of Product Characteristics No weight loss injection currently has regulatory approval for use whilst breastfeeding in the UK Transfer into breast milk and effects on nursing infants remain unknown due to absence of human studies Appetite suppression from these medications may compromise maternal nutrition needed for adequate milk production Safe alternatives include gradual dietary modification, regular physical activity, and NHS weight management programmes Women should defer weight loss medications until breastfeeding is completed and seek GP advice for postpartum weight concerns Table of Contents Weight Loss Injections and Breastfeeding: Key Safety Considerations Types of Weight Loss Injections and Their Use During Lactation Potential Risks to Breastfed Infants Alternative Approaches to Postpartum Weight Management When to Seek Medical Advice About Weight Loss While Breastfeeding Scientific References Frequently Asked Questions Weight Loss Injections and Breastfeeding: Key Safety Considerations Weight loss injections, particularly GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), have become increasingly popular for weight management
Semaglutide may not be the right medication and you may have better results with, LDN, Amlexanox and or another medication
It will evaluate the real-world effectiveness of tirzepatide in weight loss, prevention of diabetes and obesity-related complications, and also collect data on healthcare resource utilisation, health-related quality of life, participants employment status and sick days
